The advertisement promotes Nymalize, a nimodipine oral solution, highlighting its use in improving neurological outcomes in patients with subarachnoid hemorrhage. It emphasizes that Nymalize is a trusted liquid formulation and distinguishes it from generic alternatives.
Creative Information
| CID: | 39f7224f-d52d-49f3-b3a2-bf0bbfc9abb7 |
| CRID: | 25_fktzapk3 |
| Domain: | gliadel.com |
| Seat: | TTD |
| Size: | 300x250 |
| Bid: | $0.35 |
| Timestamp: | 10/31/2025, 1:42:22 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/13/2025, 4:36:18 PM | 7.12s | |
| adomain_analysis | success | 11/13/2025, 6:45:29 PM | 3.92s | |
| adomain_capture | success | 11/13/2025, 6:45:17 PM | 0.23s | |
| ad_render | success | 11/13/2025, 4:35:24 PM | 25.16s | |
| brand_mapping | success | 11/13/2025, 2:57:24 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Gliadel
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1223.81 KB | ||||||||||||||||||||||
| Render Time: | 8.25 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1243.10 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


